Henry Schein (HSIC) : $15.53 million worth of transactions were on upticks in Henry Schein (HSIC), compared to $9.56 million on downticks. The ratio between the two was 1.62, whereas, the net money flow stood at a healthy $5.97 million on Tuesdays session. The consistent buying on upticks in the stock accounted for $4.99million worth of trades. The total money flow into the stock stood at $4.99 million. The bulls and the bears were in an equilibrium as the stock closed with a loss of -0.48%. The stock was trading at $180.9, with a drop of $0.88 over the previous days close. The stock recorded 0.1% for the week.
The company Insiders own 1.27% of Henry Schein shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -15.37% . Institutional Investors own 95.76% of Henry Schein shares. During last six month period, the net percent change held by insiders has seen a change of -14.16%. In an insider trading activity,The director officer (EVP, Chief Admin. Officer) of Henry Schein Inc, Benjamin Gerald A sold 9,991 shares at $175.07 on June 2, 2016. The Insider selling transaction had a total value worth of $1,749,124. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Shares of Henry Schein, Inc. rose by 2.06% in the last five trading days and 1.43% for the last 4 weeks. Henry Schein, Inc. is up 7.43% in the last 3-month period. Year-to-Date the stock performance stands at 14.36%.
Henry Schein (NASDAQ:HSIC): On Tuesdays trading session , Opening price of the stock was $182.4 with an intraday high of $183. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $180.8. However, the stock managed to close at $180.9, a loss of 0.48% for the day. On the previous day, the stock had closed at $181.78. The total traded volume of the day was 282,571 shares.
Henry Schein, Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products, laboratory products, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins, among others. The Companys global technology and value-added services segment provides software, technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners.